BAQUASPA Sanitizer with Stain & Scale Control

2.3 Other hazards

Eye, skin and respiratory irritant, Possible skin sensitizer

Principle Routes of Exposure

Skin, eyes, ingestion Chemical Interactions: No known or reported interactions.

Medical Conditions Generally Aggravated by Exposure

None known Human Threshold Response Data Odor Threshold Not established for product. Hydrochloric Acid (32% active) 0.77 ppm Irritation Threshold Not established for product. Hazardous Materials Identification System / National Fire Protection Association Classifications

Hazard statements

Health Flammability Physical / Instability PPI / Special hazard. HMIS 2 0 NFPA 2 0 Immediate (Acute) Health Effects Inhalation Toxicity: Not expected to be toxic by inhalation. Vapors and/or aerosols which may be formed at elevated temperatures may be irritating to eyes and upper respiratory tract. Skin Toxicity: Not expected to be absorbed through the skin. Skin contact may cause moderate irritation consisting of transient redness and swelling. This irritant effect would not be expected to result in permanent damage. Eye Toxicity: Contact may cause moderate irritation consisting of transient redness, swelling, and mucous membrane discharge to the conjunctiva. Any visual impairment or corneal damage (opacity) would be expected to clear within several days. Ingestion Toxicity: Moderately toxic if swallowed. Ingestion may cause irritation of the gastrointestinal tract and gastrointestinal discomfort with any or all of the following symptoms: nausea, vomiting or diarrhea. Acute Target Organ Toxicity: May cause skin, eye and mucous membrane irritation (includes upper respiratory tract). Ingestion may cause gastrointestinal discomfort.

Potential chronic health

Carcinogenicity: This product is not known or reported to be carcinogenic by any reference source including IARC, OSHA, NTP or EPA. Reproductive and Not known or reported to cause reproductive or developmental toxicity. Developmental Toxicity: Inhalation: There are no known or reported effects from chronic exposure. Skin Contact: Repeated or prolonged skin contact may cause some individuals to develop skin rash and other skin complications due to allergic skin sensitization. PHMB when tested at 1.0% in the HRIPT, PHMB did not produce irritation or allergic skin reactions. Ingestion: There are no known or reported effects from chronic ingestion except for effects similar to those experienced from single exposure. Sensitization: Possible skin sensitizer based on animal tests PHMB when tested at 1.0% in the HRIPT, PHMB did not produce irritation or allergic skin reactions. Chronic Target Organ Toxicity: There are no known or reported effects to humans from repeated exposure to this product. Supplemental Health Hazard Polyaminopropyl Biguanide, the biocidal active in this product, has been Information : extensively studied for its toxicity to mammalian systems. Repeated inhalation exposure in rats over a period of 4 weeks resulted in eye and respiratory irritation and pneumonitis. Long term feeding studies in dogs show that the liver and kidney are target organs and the effect occur only at very high doses. Polyaminopropyl Biguanide has been shown in animal studies to produce skin sensitization. Polyaminopropyl Biguanide is not readily bioavailable if ingested and is not well absorbed through skin., PHMB when tested at 1.0% in the HRIPT, PHMB did not produce irritation or allergic skin reactions.